Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
about
Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteriaPoly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniaeInvestigational drugs to treat methicillin-resistant Staphylococcus aureusWill there ever be a universal Staphylococcus aureus vaccine?Progress toward a Staphylococcus aureus vaccineBiologically inspired strategies for combating bacterial biofilmsMolecular basis of Staphylococcus epidermidis infectionsBase pairing interaction between 5'- and 3'-UTRs controls icaR mRNA translation in Staphylococcus aureusIdentification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm MatrixAntibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogensTargeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infectionIdentification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation.Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogensAntibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.Lack of the PGA exopolysaccharide in Salmonella as an adaptive trait for survival in the host.Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.Novel targeted immunotherapy approaches for staphylococcal infection.Phase variation of poly-N-acetylglucosamine expression in Staphylococcus aureus.Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infectionMicrobiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye.Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.Why antibodies disobey the Hippocratic Oath and end up doing harm: a new clue.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesinHigh levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infectionOpsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria.Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatmentEvaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection.Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infectionVaccine assembly from surface proteins of Staphylococcus aureus.Role of a putative polysaccharide locus in Bordetella biofilm development.Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia.Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections.Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamineThe protein BpsB is a poly-β-1,6-N-acetyl-D-glucosamine deacetylase required for biofilm formation in Bordetella bronchiseptica.Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.
P2860
Q24544133-072F5E83-DD69-4ACD-868E-90F283B071D2Q24678551-88D58D63-349C-4EAE-84AA-CCFAA772378EQ26780246-8F122FFF-2039-4B86-B42D-163BA9E1DAB7Q26824837-DCC3A8FA-89DD-42B9-9B21-15F5672EF4CCQ26829702-2906378B-9F2F-4D17-8ADA-8D8AC7CBF048Q27006003-084CF249-D114-4F82-A306-87689CF359EFQ27013870-3ACC7935-83B5-44AF-BE05-101E0D9059B7Q28537794-7DB8D614-3855-4A17-A5C1-7185878B027DQ30375706-2C890755-44B7-46C3-A86D-5D1294A69BC3Q30415823-95D9AD08-D0FD-445C-830D-034C95A2FD4BQ30419079-E8AFCB2D-69BB-4D25-A246-44664E1CE27DQ33244198-232FB34A-7A9F-4182-8326-65CC02E2945EQ33487075-69CCF837-254C-48A9-8720-F3B5B879779EQ33613913-944F0089-2420-4CA6-81C1-9156A96CA64CQ33719836-B9856333-DCD2-4F74-8587-5FE3D0C258BBQ33778871-91ADC906-4692-4D8C-A563-F8833C2DF3D6Q33855583-519E1515-01FF-48BC-8F5D-76B845B9434CQ33910565-A5A733E6-4618-451A-BE65-0A19C9D9613DQ33982795-63430939-5291-4C23-ABD8-D2B1F8697AF3Q34033337-00E6AA7C-4F09-4F2C-B9C9-BAB7237CEB88Q34059043-E74E2B2B-D768-411F-AB6E-8A4047A4E254Q34090161-2F2C44E2-6919-4478-9842-FCBF910A0C7AQ34090255-BE3F8E30-64DB-4898-9109-B267D6DF385CQ34113328-690B2E1C-A8D8-450B-AC4B-A9E3E3A7C13CQ34130054-2011DC7E-2337-4251-BB34-C2A6D2BC4FD1Q34233286-17FD15A9-DA47-43BF-AC34-2E57BD1143C0Q34450382-CDC35F5D-E178-4258-953F-D343CCAEC653Q34508443-D001BF6A-DB00-4A7A-822E-E244969B2E1EQ34601937-83A042CF-A382-4947-8214-E8F9FFDA856EQ34740258-8C15B65E-F9B2-4CF3-A8B9-666EC9B8B17AQ35063930-258D4134-F7CD-429C-87A5-60017F8125DCQ35067216-A6957103-331A-4173-A030-3C20D183341AQ35130822-3D17D5E1-5E82-4540-8A4A-60749B0F17CBQ35634478-6784FA59-18A6-42AE-A6B7-2FB3B9C37679Q35689313-79CB4DF8-5E82-4FF8-9A07-F51BFEFACBF3Q35689459-6C404E7A-0F81-4EEE-9A93-9983443612D8Q35778177-3460E94B-BE13-4DB9-B267-9575972CC77EQ35913664-7DB89F9A-E049-4240-9369-B2BE8D0CC9F1Q36050043-C9FCEF4B-BAA9-47A5-BF9C-9A730B3A31B9Q36097328-0FCE37CA-43B7-4FE7-85F6-9E891078CC0B
P2860
Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Comparative opsonic and protec ...... hylococcal Poly-N-acetyl-beta-
@nl
Comparative opsonic and protec ...... acetyl-beta-(1-6)-glucosamine.
@ast
Comparative opsonic and protec ...... acetyl-beta-(1-6)-glucosamine.
@en
type
label
Comparative opsonic and protec ...... hylococcal Poly-N-acetyl-beta-
@nl
Comparative opsonic and protec ...... acetyl-beta-(1-6)-glucosamine.
@ast
Comparative opsonic and protec ...... acetyl-beta-(1-6)-glucosamine.
@en
prefLabel
Comparative opsonic and protec ...... hylococcal Poly-N-acetyl-beta-
@nl
Comparative opsonic and protec ...... acetyl-beta-(1-6)-glucosamine.
@ast
Comparative opsonic and protec ...... acetyl-beta-(1-6)-glucosamine.
@en
P2093
P2860
P1476
Comparative opsonic and protec ...... -acetyl-beta-(1-6)-glucosamine
@en
P2093
Andrea Kropec
Donald A Goldmann
Tomás Maira-Litrán
P2860
P304
P356
10.1128/IAI.73.10.6752-6762.2005
P407
P50
P577
2005-10-01T00:00:00Z